Real-time enrollment status for this common warts clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 11:57 PM UTC
| NCT Number | NCT07637734 |
| Recruiting Status | Recruiting |
| Condition | Common Warts |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Verrica Pharmaceuticals Inc. |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 18, 2026: Clinical trial NCT07637734 is currently recruiting participants. This phase3 study for common warts is actively seeking new participants at 12 locations across the United States. The study is sponsored by Verrica Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07637734 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07637734 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.